Compound Q&A
What is the market or research trend for filgotinib (CAS: 1206161-97-8)?
Answer
The market for filgotinib (CAS: 1206161-97-8) is showing steady growth, driven by its successful clinical trials and regulatory approvals for treating rheumatoid arthritis and ulcerative colitis. Research trends include exploring its efficacy in other autoimmune diseases and understanding its mechanisms of action. The trend also includes developing biosimilars and studying its potential in combination therapies. Market demand is expected to increase with ongoing clinical trials and positive responses from patients.
About
CAS No
1206161-97-8
English Name
Filgotinib
Molecular Formula
C21H23N5O3S
Molecular Weight
425.51 g/mol
SMILES
C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5
InChIKey
RIJLVEAXPNLDTC-UHFFFAOYSA-N
Last Updated: 2025-10-08 20:02
